

[ Fri, Jul 19th 2024
] - WOPRAI

[ Mon, Apr 22nd 2024
] - WOPRAI

[ Wed, Feb 21st 2024
] - WOPRAI

[ Mon, Oct 23rd 2023
] - WOPRAI

[ Fri, Oct 20th 2023
] - WOPRAI

[ Wed, Jul 26th 2023
] - WOPRAI

[ Mon, Jun 12th 2023
] - WOPRAI

[ Mon, May 08th 2023
] - WOPRAI

[ Fri, Apr 28th 2023
] - WOPRAI

[ Thu, Apr 27th 2023
] - WOPRAI

[ Fri, Mar 31st 2023
] - WOPRAI

[ Tue, Feb 28th 2023
] - WOPRAI

[ Wed, Feb 08th 2023
] - WOPRAI

[ Tue, Dec 13th 2022
] - WOPRAI

[ Thu, Oct 27th 2022
] - WOPRAI

[ Tue, Aug 30th 2022
] - WOPRAI

[ Thu, Apr 28th 2022
] - WOPRAI

[ Fri, Nov 19th 2021
] - WOPRAI

[ Tue, Nov 16th 2021
] - WOPRAI

[ Wed, Sep 15th 2021
] - WOPRAI

[ Thu, Aug 19th 2021
] - WOPRAI

[ Mon, Jun 15th 2020
] - WOPRAI

[ Wed, Dec 11th 2019
] - WOPRAI
Daniel Grosslight Maintained (CAH) at Hold with Decreased Target to $107 on, Jul 19th, 2024
Daniel Grosslight of Citigroup, Maintained "Cardinal Health, Inc." (CAH) at Hold with Decreased Target from $115 to $107 on, Jul 19th, 2024.
Daniel has made no other calls on CAH in the last 4 months.
There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 2 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Elizabeth Anderson of "Evercore ISI Group" Maintained at Hold with Decreased Target to $105 on, Tuesday, July 9th, 2024
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $110 on, Monday, May 6th, 2024
These are the ratings of the 3 analyists that currently disagree with Daniel
- Eric Coldwell of "Baird" Maintained at Buy with Increased Target to $130 on, Tuesday, July 9th, 2024
- David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $115 on, Wednesday, May 15th, 2024
- Stephen Baxter of "Wells Fargo" Maintained at Sell with Decreased Target to $94 on, Monday, April 29th, 2024